Stroke remains a significant cause of morbidity and mortality worldwide. Early recognition and swift intervention are crucial in mitigating the devastating consequences of this medical emergency. This article aims to provide healthcare professionals with a comprehensive guide to early stroke recognition and management.
Early stroke recognition is vital for prompt intervention. The BE FAST model is an effective tool for identifying potential stroke patients. B for Balance difficulties, E for Eyesight problems, F for Face drooping, A for Arm weakness, S for Speech difficulties, and T for Time to call emergency services. This model emphasizes the importance of swift action in the face of potential stroke symptoms.
Once a stroke is suspected, immediate management includes maintaining airway, breathing, and circulation, stabilizing vital signs, and initiating intravenous access. It is also crucial to obtain a rapid brain imaging study, preferably a non-contrast CT scan, to differentiate between ischemic and hemorrhagic stroke.
Acute ischemic stroke management may involve intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) if administered within 4.5 hours of symptom onset. Endovascular procedures like mechanical thrombectomy can be considered within 24 hours in certain patients. Hemorrhagic stroke management focuses on controlling blood pressure, reversing anticoagulation, and surgical intervention when indicated.
Stroke recognition and management require a systematic approach. Utilizing the BE FAST model can facilitate early identification of symptoms. Immediate stabilization, appropriate imaging, and timely intervention can significantly improve patient outcomes. As healthcare professionals, staying abreast of the latest guidelines and advancements in stroke care is paramount.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation